RIO DE JANEIRO, BRAZIL - Chinese pharmaceutical company Sinopharm reported its vaccine developed against the novel coronavirus is safe and has proven successful in developing strong antibodies in stages 1 and 2 of trials. All trial subjects were administered two doses of the vaccine every three to four weeks and developed antibodies . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here